FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
Aug 19, 2026
View online
FDA Grants HDE Approval to OncoSil for Distal Cholangiocarcinoma
FDA Lists More Than 1,500 AI-Enabled Medical Devices as Oncology Applications Expand
Merck and Moderna’s Intismeran Autogene Plus Keytruda Meets Phase 3 RFS and DMFS Endpoints in Resected Melanoma
Charles Roberts Named the Next President and CEO of St. Jude Children’s Research Hospital
KENCO and OncoDaily Announce Strategic Partnership
Bridging the Care Gap: Expanding Humanitarian Access to CLL Treatment Across LMICs
2026 Early Career Researcher Awardees Receive More Than $1 Million in Funding – PICI
Community Oncology Global Congress 2026
Cancer Research UK Early Detection and Diagnosis Primer Award 2026
Cancer Research UK Clinical Research Funding Scheme 2026
ESTRO Meets Asia 2026
The AORTICHORG 3rd Quarterly Webinar
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
